Prohost Letters
Premium
Prohost Letter #404 Part 2
Prohost Letter #404 Part 2 Synthetic Biology (2) A Brief History DNA is the software of life. This is how Synthetic Genomics firm, which we believe is now is the leading biotech firm for applied synth...
P
Prohost Biotech
1 min read
3
0
Unlock Premium Content
This article contains exclusive content for our premium subscribers. Join our community to access in-depth research, expert insights, and comprehensive analysis.
Unlimited articles
Expert analysis
Research reports
Tags
Agenus (AGEN)
Alnylam Pharmaceuticals (ALNY)
Amgen (AMGN)
Array BioPharma (ARRY)
Bellicum Pharmaceuticals Inc (BLCM)
CAR-T
CRISPR Therapeutics (CRSP)
Exelixis (EXEL)
Exxon Mobil
Gilead Sciences (GILD)
ImmunoGen (IMGN)
Incyte (INCY)
Ionis Pharmaceuticals Inc (IONS)
Juno Therapeutics (JUNO)
Kite Pharma - A Gilead Company
Monsanto Co (MON)
Nektar Therapeutics (NKTR)
Novartis (NVS)
Portola Pharmaceuticals Inc (PTLA)
Prohost Portfolio
Regeneron Pharmaceuticals (REGN)
Seagen Inc (SGEN)
Synthetic Genomics
Theravance Biopharma (TBPH)
United Therapeutics (UTHR)
Xoma (XOMA)
Comments (0)
Please sign in to join the discussion